LJI discovery paves the way for antivirals against Ebola virus and its deadly relatives
Scientists capture first look at key viral structure within infected host cells
LJI scientists win ‘Prebys Research Heroes’ funding
Prebys Foundation celebrates ground-breaking female researchers
Erica Ollmann Saphire wins 2023 Pantheon Award from California Life Sciences
LJI President and CEO celebrated among California’s leading life sciences innovators
A new look inside Ebola’s ‘viral factories’
LJI researchers reveal a hidden side of how Ebola virus replicates inside host cells
LJI scientists uncover the structure and function of Inmazeb, the first FDA-approved drug for Ebola virus infection
LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved
Targeting a human protein may stop Ebola virus in its tracks
LA JOLLA, CA—To treat Ebola virus infections, researchers are taking a close look at a key piece of the virus:
Promising antibody cocktail takes on Ebola virus—and its deadly cousin
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its
Learning from men. Learning from women.
Men and women have different immune systems. With a better understanding of sex-specific immune differences, scientists can more effectively fight infections, cancers, heart disease, and even pregnancy complications.
Shape-shifting Ebola virus protein exploits human RNA to change shape
New study highlights VP40 as a promising therapeutic target
Up and Coming: Haoyang Li, Ph.D. – An Inspired Vaccine
Haoyang Li, Ph.D., is no stranger to quarantine. He was in high school in China when SARS came knocking. “My
Saphire Lab
Erica Ollmann Saphire,
Ph.D., MBA
Professor, President & Chief Executive Officer
Center for Autoimmunity and Inflammation, Center for Cancer Immunotherapy, Center for Sex-based Differences in the Immune System, Center for Vaccine Innovation
Erica Ollmann Saphire, Ph.D., MBA, studies, at the molecular level, how and why viruses are pathogenic. This work provides the roadmap for medical defense.
Building a world-class imaging facility
During the last week of August, the trucks finally started to arrive. Carefully nestled inside 22 huge wooden crates was